Fatty Acids, Unsaturated clinical trials
How each study uses Fatty Acids, Unsaturated is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Fatty Acids, Unsaturated
- 1
Studies by the year they started
6 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2016 | 2 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 6
Hadir F. El-Dessouky (1) · Institute of Liver and Biliary Sciences, India (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · Wroclaw Medical University (1) · University of Western Ontario, Canada (1)
Studies
Open first, then newest update. How each study uses Fatty Acids, Unsaturated is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Treatment of Periodontitis in Menopausal PatientsCompletedPhase 4Hadir F. El-DessoukyNCT06254118Written as Polyunsaturated Fatty Acids
- The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.Status unknownPhase 3Wroclaw Medical UniversityNCT04743050Written as Fatty Acids, Unsaturated
- To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver FailureCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT02691533Written as ω3 PUFA (Polyunsaturated fatty acids) (10% Omegavan 100 ml)
- Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty LiverCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00323414Written as Polyunsaturated fatty acid (Opti-EPA)
- Effect of Plant Omega-3 and Omega-6 Fatty Acids on Exercise PerformanceStatus unknownNot applicableUniversity of Western Ontario, CanadaNCT02654392Written as Polyunsaturated fatty acid
- PUFA Augmentation in Treatment of Major DepressionCompletedPhase 3National Center for Complementary and Integrative Health (NCCIH)NCT00067301Written as Polyunsaturated Fatty Acids (PUFA)